Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
Go back to Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites| (NASDAQ: MBOT) | Delayed: 1.85 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.85 | 52 Week High | $ | |||
| Open | $1.85 | 52 Week Low | $ | |||
| Day High | $1.85 | P/E | N/A | |||
| Day Low | $1.85 | EPS | $ | |||
| Volume | 20,639 | |||||

